2021 Investor Day

Competitive advantages to accelerate operational excellence Unique, medically-focused culture with emphasis on quality of treatment Industry leader with strong reputation for innovation and quality Recognized, trusted data partner for systems and clients Expertise in collecting and analyzing complex clinical data • Substantial operational scale drives cost-leadership Strong supply chain providing high-quality products in volume Long-term performance driven by ResMedian culture of continuous improvement O2021 ResMed | 2021 Investor Day – Sept 8, 2021 - 67

View entire presentation